News & Perspective

May 10, 2018

May 10, 2018

News Scan for May 10, 2018

Canadian romaine E coli cases
Burkholderia cepacia outbreak
Yellow fever in Brazil
Avian flu outbreaks
Polio emergency continues

Feb 05, 2018

Feb 05, 2018

Stewardship / Resistance Scan for Feb 05, 2018

Drug-resistant gonorrhea in Americas
MDR-TB treatment

Dec 15, 2017

Dec 15, 2017

News Scan for Dec 15, 2017

E coli lettuce outbreak
Netherlands detects H5N6
H7N9 and market closures
Yellow fever in Brazil, Peru
Polio in Pakistan, Syria

Nov 17, 2017

Nov 17, 2017

ASP Scan (Weekly) for Nov 17, 2017

Primary care stewardship
No-touch superbug disinfection
Surgical antimicrobial prescribing
Ceftriaxone-resistant gonorrhea
E coli ST131
Single-room ICU design
ECDC CRE guidance
European research funding
Optimal MDR-TB treatment
Real-time resistance tracker
Salmonella in calves
Drug-resistant malaria controversy
US AMR progress
Antimicrobial use in Northern Ireland
Resistance in space

May 18, 2011

May 18, 2011

Experts: Regulatory issues are main reason for keeping smallpox virus

(CIDRAP News) – When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»